On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge of a range of global health threats. These diseases – HIV/AIDS, tuberculosis (TB), antimicrobial-resistant enteric infections, and COVID-19 – were estimated to have caused at least 95 million new infections and more than 4 million deaths in 2020 alone.